Lucid Diagnostics (LUCD) Short Interest Ratio & Short Volume → Dems have chosen Biden replacement? (From Paradigm Press) (Ad) Free LUCD Stock Alerts $0.95 -0.08 (-7.77%) (As of 05/8/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Lucid Diagnostics Short Interest DataCurrent Short Volume361,400 sharesPrevious Short Volume441,000 sharesChange Vs. Previous Month-18.05%Dollar Volume Sold Short$292,734.00Short Interest Ratio / Days to Cover2.2Last Record DateApril 15, 2024Outstanding Shares49,780,000 sharesFloat Size14,290,000 sharesShort Percent of Float2.53%Today's Trading Volume276,546 sharesAverage Trading Volume166,500 sharesToday's Volume Vs. Average166% Short Selling Lucid Diagnostics ? Sign up to receive the latest short interest report for Lucid Diagnostics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatLUCD Short Interest Over TimeLUCD Days to Cover Over TimeLUCD Percentage of Float Shorted Over Time Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now Lucid Diagnostics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024361,400 shares $292,734.00 -18.1%2.5%2.2 $0.81 3/31/2024441,000 shares $357,165.90 +91.1%3.8%3.1 $0.81 3/15/2024230,800 shares $256,188.00 +13.9%2.3%2.2 $1.11 2/29/2024202,600 shares $249,198.00 +9.6%2.0%2.8 $1.23 2/15/2024184,900 shares $253,313.00 +46.1%1.8%3 $1.37 1/31/2024126,600 shares $178,506.00 +16.4%1.8%2.8 $1.41 Get the Latest News and Ratings for LUCD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lucid Diagnostics and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024108,800 shares $165,376.00 -8.5%1.0%2.7 $1.52 12/31/2023118,900 shares $167,649.00 -25.4%1.1%3.1 $1.41 12/15/2023159,300 shares $208,683.00 +32.8%1.5%3.5 $1.31 11/30/2023120,000 shares $177,600.00 +0.8%1.2%2.8 $1.48 11/15/2023119,100 shares $158,403.00 +9.6%1.2%2.7 $1.33 10/31/2023108,700 shares $140,223.00 +12.4%1.1%2.4 $1.29 10/15/202396,700 shares $117,974.00 -2.8%1.0%2.2 $1.22 9/30/202399,500 shares $116,415.00 +0.4%1.0%2.1 $1.17 9/15/202399,100 shares $150,632.00 +14.6%1.0%2.3 $1.52 8/31/202386,500 shares $133,210.00 -15.4%0.9%1.7 $1.54 8/15/2023102,300 shares $152,427.00 -12.9%1.0%1.9 $1.49 7/31/2023117,400 shares $164,360.00 -1.1%1.2%2.2 $1.40 7/15/2023118,700 shares $157,871.00 -20.8%1.2%2.2 $1.33 6/30/2023149,900 shares $208,361.00 +5.6%1.5%2.6 $1.39 6/15/2023141,900 shares $227,040.00 +21.8%1.4%2.2 $1.60 5/31/2023116,500 shares $185,235.00 +12.0%1.2%1.6 $1.59 5/15/2023104,000 shares $154,960.00 -35.4%1.1%1.2 $1.49 4/30/2023160,900 shares $236,523.00 +32.2%1.4%1.7 $1.47 4/15/2023121,700 shares $165,512.00 -35.4%1.1%1.2 $1.36 3/31/2023188,300 shares $263,620.00 +41.1%2.3%1.7 $1.40 3/15/2023133,500 shares $236,295.00 -19.0%1.7%1.3 $1.77 2/28/2023164,800 shares $224,128.00 +13.1%2.2%1.8 $1.36 2/15/2023145,700 shares $190,867.00 -30.0%2.0%1.8 $1.31 1/31/2023208,100 shares $272,611.00 -4.3%2.8%2.9 $1.31 1/15/2023217,400 shares $282,620.00 -0.4%3.0%3.1 $1.30 12/30/2022218,200 shares $296,752.00 +32.6%3.0%3.8 $1.36 12/15/2022164,500 shares $268,135.00 -33.2%2.2%2.7 $1.63 11/30/2022246,100 shares $457,746.00 +17.0%3.6%3.9 $1.86 11/15/2022210,300 shares $420,600.00 +33.9%2.9%3.2 $2.00 10/31/2022157,100 shares $301,632.00 -4.4%2.2%2 $1.92 10/15/2022164,300 shares $280,953.00 -23.2%2.4%1.8 $1.71 9/30/2022213,800 shares $327,114.00 +20.7%3.1%2.3 $1.53 9/15/2022177,200 shares $363,260.00 -8.9%2.5%1.8 $2.05 8/31/2022194,500 shares $422,065.00 -11.6%2.9%1.9 $2.17Biden replacement revealed? (Ad)A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.See his shocking evidence in this new report LUCD Short Interest - Frequently Asked Questions What is Lucid Diagnostics' current short interest? Short interest is the volume of Lucid Diagnostics shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 361,400 shares of LUCD short. 2.53% of Lucid Diagnostics' shares are currently sold short. Learn More on Lucid Diagnostics' current short interest. What is a good short interest ratio for Lucid Diagnostics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LUCD shares currently have a short interest ratio of 2.0. Learn More on Lucid Diagnostics's short interest ratio. What is a good short interest percentage for Lucid Diagnostics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.53% of Lucid Diagnostics' floating shares are currently sold short. Is Lucid Diagnostics' short interest increasing or decreasing? Lucid Diagnostics saw a decline in short interest in April. As of April 15th, there was short interest totaling 361,400 shares, a decline of 18.0% from the previous total of 441,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Lucid Diagnostics' float size? Lucid Diagnostics currently has issued a total of 49,780,000 shares. Some of Lucid Diagnostics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Lucid Diagnostics currently has a public float of 14,290,000 shares. How does Lucid Diagnostics' short interest compare to its competitors? 2.53% of Lucid Diagnostics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Lucid Diagnostics: Cytosorbents Co. (2.85%), DarioHealth Corp. (4.65%), Daxor Co. (0.62%), Beyond Air, Inc. (8.91%), Carmell Co. (0.18%), Apyx Medical Co. (1.31%), Co-Diagnostics, Inc. (1.45%), SeaStar Medical Holding Co. (6.36%), LENSAR, Inc. (0.73%), Modular Medical, Inc. (0.68%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Lucid Diagnostics stock? Short selling LUCD is an investing strategy that aims to generate trading profit from Lucid Diagnostics as its price is falling. LUCD shares are trading down $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Lucid Diagnostics? A short squeeze for Lucid Diagnostics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LUCD, which in turn drives the price of the stock up even further. How often is Lucid Diagnostics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LUCD, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: CTSO Short Squeeze APYX Short Squeeze DRIO Short Squeeze ICCM Short Squeeze XAIR Short Squeeze DXR Short Squeeze PDEX Short Squeeze SRTS Short Squeeze MGRM Short Squeeze CTCX Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LUCD) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm Press348 million Americans lives to END as we know it?The Oxford ClubThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeHow Biden has already won 2024Porter & Company